Rapt Therapeutics, Inc. (RAPT)

33.48 -0.92 (-2.66%) USD  |  NASDAQ  |  Jan 13, 10:17
More

Rapt Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade